Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Maes

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Sciences|October 5, 2019
PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic ReviewChristophe Van de Wiele, Mike Sathekge, Bart de Spiegeleer, et al.
Biomedicines|August 28, 2020
Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A ReviewAnne-Leen Deleu, Machaba Junior Sathekge, Alex Maes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2012
SIRT of liver metastases: physiological and pathophysiological considerationsChristophe Van de Wiele, Alex Maes, Eddy Brugman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 5, 2003
The value of (18)FDG-PET for the detection of infected hip prosthesisBenedicte Vanquickenborne, Alex Maes, Johan Nuyts, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-AfricansMike Sathekge, Thabo Lengana, Alex Maes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Cardiac phantom measurement validating the methodology for a cardiac multi-centre trial with positron emission tomographyJohan Nuyts, Luc Mortelmans, Frans Van de Werf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2016
<sup>68</sup>Ga-PSMA-HBED-CC PET imaging in breast carcinoma patientsMike Sathekge, Thabo Lengana, Moshe Modiselle, et al.
Seminars in Nuclear Medicine|July 11, 2021
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma PatientsChristophe Van de Wiele, Gebreurs Juanito, Borght K Vander, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2016
Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinomaChristophe Van de Wiele, Mathias Van Vlaenderen, Ludovic D'Hulst, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin caseNathalie Bracke, Yorick Janssens, Evelien Wynendaele, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Sciences|October 5, 2019
PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic ReviewChristophe Van de Wiele, Mike Sathekge, Bart de Spiegeleer, et al.
Biomedicines|August 28, 2020
Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A ReviewAnne-Leen Deleu, Machaba Junior Sathekge, Alex Maes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2012
SIRT of liver metastases: physiological and pathophysiological considerationsChristophe Van de Wiele, Alex Maes, Eddy Brugman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 5, 2003
The value of (18)FDG-PET for the detection of infected hip prosthesisBenedicte Vanquickenborne, Alex Maes, Johan Nuyts, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-AfricansMike Sathekge, Thabo Lengana, Alex Maes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Cardiac phantom measurement validating the methodology for a cardiac multi-centre trial with positron emission tomographyJohan Nuyts, Luc Mortelmans, Frans Van de Werf, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2016
<sup>68</sup>Ga-PSMA-HBED-CC PET imaging in breast carcinoma patientsMike Sathekge, Thabo Lengana, Moshe Modiselle, et al.
Seminars in Nuclear Medicine|July 11, 2021
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma PatientsChristophe Van de Wiele, Gebreurs Juanito, Borght K Vander, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2016
Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma : Metabolic and morphological fat measurements in pancreatic adenocarcinomaChristophe Van de Wiele, Mathias Van Vlaenderen, Ludovic D'Hulst, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
Blood-brain barrier transport kinetics of NOTA-modified proteins: the somatropin caseNathalie Bracke, Yorick Janssens, Evelien Wynendaele, et al.
Pageof 8